The value of immunohistochemical markers in the diagnosis of cervical neoplasia
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1984.tb03684.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b)
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 91, Issue 10, pages 1037–1041, October 1984
Additional Information
How to Cite
FRAY, R. E., HUSAIN, O. A. N., TO, A. C. W., WATTS, K. C., LADER, S., ROGERS, G. T., TAYLOR-PAPADIMITRIOU, J. and MORRIS, N. F. (1984), The value of immunohistochemical markers in the diagnosis of cervical neoplasia. BJOG: An International Journal of Obstetrics & Gynaecology, 91: 1037–1041. doi: 10.1111/j.1471-0528.1984.tb03684.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Received 4 November 1983 Accepted 5 February 1984
- Abstract
- References
- Cited By
Summary. This study was designed to determine whether immunohistochemical stains for tumour-associated markers may be useful in the detection and differential diagnosis of premalignant and malignant lesions of the cervix. The expression of four markers detected by monoclonal antibodies, human milk fat globule 1 and 2 (HMFG-1 and 2), Cal and anti-carcinoembryonic antigen (anti-CEA) on conventional histological sections of various cervical lesions has been investigated. None of these markers was specific for neoplastic lesions of the cervix and all four markers were expressed by metaplastic as well as neoplastic cells, and it was concluded that their application in the histopathological examination of the cervix is limited.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)